| Page 447 | Kisaco Research
 

Sabina Kineen

Rare Disease Patient, Caregiver, Advocate

Sabina Kineen

Rare Disease Patient, Caregiver, Advocate

Sabina Kineen

Rare Disease Patient, Caregiver, Advocate
 

Quincy Byrdsong

Vice President of Research Operations
Ballad Health

Quincy Byrdsong

Vice President of Research Operations
Ballad Health

Quincy Byrdsong

Vice President of Research Operations
Ballad Health
  • How are we ensuring under-served patient populations voices are considered in trial format?
  • Optimizing both population data and clinical data analytics to develop accessible and equitable clinical trials. 
health equity
clinical trials

Author:

Brittany Gerald

Clinical Trial Health Equity Leader & Founder
Pathway to Pharma

Brittany earned her Bachelor of Science degree from Wake Forest University and brings over 17 years of experience in clinical research across the Sponsor, CRO, and Site levels. Her expertise spans a wide range of therapeutic areas, including cardiology, endocrinology, immunology, neurology, oncology, women’s health, and vaccines. Throughout her career, Brittany has contributed to more than 45 clinical trials, working with various pharmaceutical companies and Contract Research Organizations.

A passionate advocate for health equity, Brittany is dedicated to promoting health equity and representation in clinical research. She actively participates in discussions and panels focused on equity in clinical trials, sharing her knowledge and strategies for fostering inclusivity. Her leadership and commitment to ensuring representation in clinical research plays a pivotal role in advancing health outcomes for all communities, building trust, and making medical innovations accessible to everyone.

Brittany Gerald

Clinical Trial Health Equity Leader & Founder
Pathway to Pharma

Brittany earned her Bachelor of Science degree from Wake Forest University and brings over 17 years of experience in clinical research across the Sponsor, CRO, and Site levels. Her expertise spans a wide range of therapeutic areas, including cardiology, endocrinology, immunology, neurology, oncology, women’s health, and vaccines. Throughout her career, Brittany has contributed to more than 45 clinical trials, working with various pharmaceutical companies and Contract Research Organizations.

A passionate advocate for health equity, Brittany is dedicated to promoting health equity and representation in clinical research. She actively participates in discussions and panels focused on equity in clinical trials, sharing her knowledge and strategies for fostering inclusivity. Her leadership and commitment to ensuring representation in clinical research plays a pivotal role in advancing health outcomes for all communities, building trust, and making medical innovations accessible to everyone.

Author:

Benjamin Young

Senior Global Medical Director
ViiV Healthcare

Benjamin Young

Senior Global Medical Director
ViiV Healthcare

Author:

Sandra Amaro

Head of Clinical Trial Diversity
Pfizer

Sandra Amaro

Head of Clinical Trial Diversity
Pfizer
  • Discussing implementation of RWE in upstream and downstream clinical operations to improve diversity strategy.
  • Platforming cases of qualitative data retrieval and how this aids understanding of under-served populations.
health equity
Data
clinical trials

Author:

Mary Nwokedi

Director, Clinical Trial Diversity: Science and Regulatory Advocacy
PhRMA

Mary Nwokedi

Director, Clinical Trial Diversity: Science and Regulatory Advocacy
PhRMA

Author:

Kemi Willaims

Senior Director, Patient Science
AstraZeneca

Kemi Willaims

Senior Director, Patient Science
AstraZeneca
  • Platforming the tangible successes pharmaceutical companies are having to improve DEI in clinical trials.
  • Highlighting data-driven strategies to improve site capabilities for underserved-patient engagement, recruitment, and experience.
  • The importance of collaboration and standardization from a large-scale initative perspective, where are we at and where do we need to be.

Author:

Michel Reid

Senior Director & Head, Global Demographics & Diversity
GSK

Michel Reid

Senior Director & Head, Global Demographics & Diversity
GSK

Author:

Alana Miller

Alana Miller

Author:

Monique Adams

Executive Director, Diversity & Inclusion in Clinical Trials
Sanofi

Monique Adams

Executive Director, Diversity & Inclusion in Clinical Trials
Sanofi
  • Patients are the quality control of health equity developments, sharing experiences of clinical trial participation, highlighting the successes of improved patient experience.
  • What can the industry learn from patient experts, discussing the implementation of patient voice into health equity strategic programs.
  • Includes an open Q&A towards the end of the panel to ask critical questions to patients and facilitate industry learning. 
health equity

Author:

Allison Kalloo

Patient Advocate & CEO
Clinical Ambassador

Allison Kalloo

Patient Advocate & CEO
Clinical Ambassador

Author:

Sabina Kineen

Rare Disease Patient, Caregiver, Advocate

Sabina Kineen

Rare Disease Patient, Caregiver, Advocate
 

Sabina Kineen

Rare Disease Patient, Caregiver, Advocate

Sabina Kineen

Rare Disease Patient, Caregiver, Advocate

Sabina Kineen

Rare Disease Patient, Caregiver, Advocate
 

Allison Kalloo

Patient Advocate & CEO
Clinical Ambassador

Allison Kalloo

Patient Advocate & CEO
Clinical Ambassador

Allison Kalloo

Patient Advocate & CEO
Clinical Ambassador
Enterprise Gen AI - CVS Health - Attendee Spotlight